PDL BioPharma, Inc. (NASDAQ:PDLI)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Recs

0
Player Avatar zlot (81.83) Submitted: 5/2/2011 4:24:09 PM : Outperform Start Price: $5.87 PDLI Score: +13.20

I like cheap(<$15) dividend-producing stocks. This has a pretty good record, and although it's currently heavily shorted, I still think it's going to be great for my retirement.

Report this Post Reply

Featured Broker Partners


Advertisement